Currently, prostate cancer is typically diagnosed by conducting a biopsy on men who have elevated levels of serum prostate-specific antigen (PSA) and/or exhibit abnormal digital rectal examination (DRE) results. This evidence concerns the gene KLK3 and Familial prostate cancer.